Spiremed Pharmaceuticals

Spiremed Pharmaceuticals is an Indian pharmaceutical company based in Mumbai, specializing in the manufacturing and marketing of therapeutic supplements and pharmacological treatments. Founded in 2019, the company focuses on addressing neurological health and nutritional deficiencies through established combination therapies. Its flagship product, Spinerve, is a combination of alpha-lipoic acid, folic acid, methylcobalamin, and pyridoxine designed to treat various forms of neuropathic pain, including diabetic and alcoholic neuropathy. Spiremed operates primarily in the domestic Indian market, distributing its products through major healthcare networks and retail pharmacy platforms. The company maintains an active status and also engages in the production of specialized chemical preparations and consumer health products.